Results 181 to 190 of about 457,015 (304)

Updates on Recent Advancements in Hepatitis D Virus Treatment. [PDF]

Viruses
Bardak AE, Ozturk NB, Gurakar M, Sequeira L, Yildiz E, Ozmert EH, Idilman R, Gurakar A.   +7 more
europepmc   +1 more source

Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment

British Journal of Clinical Pharmacology, EarlyView.
Aims Crisugabalin is a novel calcium channel α2δ subunit ligand and a highly selective oral gamma‐aminobutyric acid (GABA) analogue developed for the treatment of diabetic peripheral neuropathic pain (DPNP) and postherpetic neuralgia (PHN). This study investigated pharmacokinetic properties and safety of crisugabalin in subjects with renal impairment ...
Shibeilei Lin, Ye Wang, Chao Hu, Yanhuan Feng, Xi Tang, Ping Fu, Jia Miao   +6 more
wiley   +1 more source

CRISPR/Cas13a-Assisted accurate and portable hepatitis D virus RNA detection. [PDF]

Emerg Microbes Infect, 2023
Tian Y, Fan Z, Zhang X, Xu L, Cao Y, Pan Z, Mo Y, Gao Y, Zheng S, Huang J, Zou H, Duan Z, Li H, Ren F.   +13 more
europepmc   +1 more source

Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review

Clinical Anatomy, EarlyView.
ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley   +1 more source

The Challenge of Hepatitis D Virus Coinfection in Iran: Age, Access, and Unanswered Public Health Questions. [PDF]

Iran J Med Sci
Byeon H.
europepmc   +1 more source

Recent treatment advances and practical management of hepatitis D virus. [PDF]

Clin Med (Lond), 2023
Olsen K, Mahgoub S, Al-Shakhshir S, Algieder A, Atabani S, Bannaga A, Elsharkawy AM.   +6 more
europepmc   +1 more source

Lipid Profile Differences in HIV‐Infected Populations With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis

Chronic Diseases and Translational Medicine, EarlyView.
PRISMA study flow diagram. ABSTRACT Introduction Advances in HIV management have transformed HIV into a chronic condition, resulting in improved prognosis and increased survival among people living with HIV (PLWH). Traditional risk factors for metabolic dysfunction‐associated steatotic liver disease (MASLD)—including dyslipidemia—are prevalent in PLWH.
Yovita Hartantri, Sherly Lawrensia, Steven Yulius Usman, Nenny Agustanti, Rudi Wisaksana, Nanny Natalia Mulyani Soetedjo, Bachti Alisjahbana   +6 more
wiley   +1 more source

The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm. [PDF]

Liver Int
Caviglia GP, Dileo E, Olivero A, Mengozzi G, Ciancio A, Loglio A, Viganò M, Fagiuoli S, Colombatto P, Coco B, Brunetto MR, Angrisani D, Galeota Lanza A, Magni C, Rizzardini G, Messina V, Milella M, Saracino A, Marinaro L, Cariti G, Cossiga V, Morisco F, Cretella S, Verucchi G, Biliotti E, D'Offizi G, Feasi M, Pontali E, Coppola C, Rapetti R, Pirisi M, Izzi A, Santantonio T, Di Marco V, Marrone A, Coppola N, Rizzi M, Cattelan AM, Niro GA, Toniutto P, Ponziani FR, Belli LS, Federico A, Bertino G, Barone M, Puoti M, Civolani A, Distefano M, Surace LA, Cozzolongo R, Cela EM, Teti E, Lampertico P, Stroffolini T, Rizzetto M, HDV Describe Study Group.   +55 more
europepmc   +1 more source

Cellular Factors Involved in the Hepatitis D Virus Life Cycle. [PDF]

Viruses, 2023
Thiyagarajah K, Basic M, Hildt E.
europepmc   +1 more source

Conformational Trajectory of the Molecular Chameleon Grazoprevir from Formulation to Target‐Bound

Chemistry – A European Journal, EarlyView.
ABSTRACT Macrocycles represent a promising class of beyond‐rule‐of‐5 (bRo5) therapeutics, capable of targeting proteins traditionally considered undruggable by conventional small molecules. Macrocycles exhibit intrinsic flexibility and often display a “chameleon‐like” ability to adapt to their environment, thereby enhancing their oral bioavailability ...
Lianne H. E. Wieske, Guanhong Bu, Máté Erdélyi, Jan Kihlberg, Tamir Gonen, Emma Rova Danelius   +5 more
wiley   +1 more source